Role of human TRIM5α in intrinsic immunity

Frontiers in Microbiology

Volumn 3, Issue MAR, 2012, Pages

  Nakayama, Emi E ^a   Shioda, Tatsuo ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Capsid; Fv1; HIV 1; HIV 2; SIV; TAB2; TRIM5 ; TRIMCyp

Indexed keywords

EID: 84866103902     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00097     Document Type: Article

References (141)

1. Ahmed, N., Hayashi, T., Hasegawa, A., Furukawa, H., Okamura, N., Chida, T., Masuda, T., and Kannagi, M. (2010). Suppression of human immunodeficiency virus type 1 replication in macrophages by commensal bacteria preferentially stimulating Toll-like receptor 4. J. Gen. Virol. 91, 2804-2813.
2. Anderson, J. L., Campbell, E. M., Wu, X., Vandegraaff, N., Engelman, A., and Hope, T. J. (2006). Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J. Virol. 80, 9754-9760.
3. Ariyoshi, K., Jaffar, S., Alabi, A. S., Berry, N., Schim Van Der Loeff, M., Sabally, S., N'Gom, P. T., Corrah, T., Tedder, R., and Whittle, H. (2000). Plasma RNA viral load predicts the rate of CD4Tcell decline and deathinHIV-2-infected patients in West Africa. AIDS 14, 339-344.
4. Asaoka, K., Ikeda, K., Hishinuma, T., Horie-Inoue, K., Takeda, S., and Inoue, S. (2005). A retrovirus restriction factor TRIM5alpha is tran-scriptionally regulated by interferons. Biochem. Biophys. Res. Commun. 338, 1950-1956.
5. Bassin, R. H., Duran-Troise, G., Gerwin, B. I., and Rein, A. (1978). Abrogation of Fv-1b restriction with murine leukemia viruses inactivated by heat or by gamma irradiation. J. Virol. 26, 306-315.
6. Battivelli, E., Migraine, J., Lecossier, D., Yeni, P., Clavel, F., and Hance, A. J. (2011). Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5alpha, linking intrinsic and acquired immunity. J. Virol. 85, 11846-11854.
7. Benit, L., De Parseval, N., Casella, J. F., Callebaut, I., Cordonnier, A., and Heidmann, T. (1997). Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene. J. Virol. 71, 5652-5657.
8. Berry, N., Ariyoshi, K., Balfe, P., Tedder, R., and Whittle, H. (2001). Sequence specificity of the human immunodeficiency virus type 2 (HIV-2) long terminal repeat u3 region in vivo allows subtyping of the principal HIV-2 viral subtypes a and b. AIDS Res. Hum. Retroviruses 17, 263-267.
9. Besnier, C., Takeuchi, Y., and Towers, G. (2002). Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. U.S.A. 99, 11920-11925.
10. Best, S., Le Tissier, P., Towers, G., and Stoye, J. P. (1996). Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382, 826-829.
11. Bishop, K. N., Bock, M., Towers, G., and Stoye, J. P. (2001). Identification of the regions of Fv1 necessary for murine leukemia virus restriction. J. Virol. 75, 5182-5188.
12. Bishop, K. N., Mortuza, G. B., Howell, S., Yap, M. W., Stoye, J. P., and Taylor,I. A. (2006). Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1. J. Virol. 80, 8225-8235.
13. Bock, M., Bishop, K. N., Towers, G., and Stoye, J. P. (2000). Use of a transient assay for studying the genetic determinants of Fv1 restriction. J. Virol. 74, 7422-7430.
14. Boone, L. R., Innes, C. L., and Heitman, C. K. (1990). Abrogation of Fv-1 restriction by genome-deficient virions produced by a retrovirus packaging cell line. J. Virol. 64, 3376-3381.
15. Brenchley, J. M., and Douek, D. C. (2008). The mucosal barrier and immune activation in HIV patho-genesis. Curr Opin HIV AIDS 3, 356-361.
16. Brennan, G., Kozyrev, Y., and Hu, S. L. (2008). TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc. Natl. Acad. Sci. U.S.A. 105, 3569-3574.
17. Brennan, G., Kozyrev, Y., Kodama, T., and Hu, S. L. (2007). Novel TRIM5 isoforms expressed by Macaca nemestrina. J. Virol. 81, 12210-12217.
18. Carthagena, L., Parise, M. C., Ringeard, M., Chelbi-Alix, M. K., Hazan, U., and Nisole, S. (2008). Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities. Retrovirology 5, 59.
19. Castro, B. A., Barnett, S. W., Evans, L. A., Moreau, J., Odehouri, K., and Levy, J. A. (1990). Biologic heterogeneity of human immunodeficiency virus type 2 (HIV-2) strains. Virology 178, 527-534.
20. Castro, B. A., Nepomuceno, M., Lerche, N. W., Eichberg, J. W., and Levy, J. A. (1991). Persistent infection of baboons and rhesus monkeys with different strains of HIV-2. Virology 184, 219-226.
21. Cowan, S., Hatziioannou, T., Cunningham, T., Muesing, M. A., Gottlinger, H. G., and Bieniasz,P. D. (2002). Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. U.S.A. 99, 11914-11919.
22. DesGroseillers, L., and Jolicoeur, P. (1983). Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses. J. Virol. 48, 685-696.
23. Diaz-Griffero, F., Qin, X. R., Hayashi, F., Kigawa, T., Finzi, A.,Sarnak,Z., Lienlaf, M., Yokoyama, S., and Sodroski, J. (2009). A B-box 2 surface patch important for TRIM5alpha self-association, capsid-binding avidity and retrovirus restriction. J. Virol. 83, 10737-10751.
24. Dietrich, E. A., Brennan, G., Ferguson, B., Wiseman, R. W., O'Connor, D., and Hu, S. L. (2011). Variable prevalence and functional diversity of the antiretroviral restriction factor TRIMCyp in Macaca fascicularis. J. Virol. 85, 9956-9963.
25. Fujita, M., Yoshida, A., Sakurai, A., Tatsuki, J., Ueno, F., Akari, H., and Adachi, A. (2003). Susceptibility of HVS-immortalized lymphocytic HSC-F cells to various strains and mutants of HIV/SIV. Int. J. Mol. Med. 11, 641-644.
26. Ganser-Pornillos, B. K., Chandrasekaran, V., Pornillos, O., Sodroski, J. G., Sundquist, W. I., and Yeager, M. (2011). Hexagonal assembly of a restricting TRIM5alpha protein. Proc. Natl. Acad. Sci. U.S.A. 108, 534-539.
27. Gatanaga, H., Das, D., Suzuki, Y., Yeh, D. D., Hussain, K. A., Ghosh, A. K., and Mitsuya, H. (2006). Altered HIV-1 Gag protein interactions with cyclophilin A (CypA) on the acquisition of H219Q and H219P substitutions in the CypA binding loop. J. Biol. Chem. 281, 1241-1250.
28. Gatanaga, H., Suzuki, Y., Tsang, H., Yoshimura, K., Kavlick, M. F., Nagashima, K., Gorelick, R. J., Mardy, S., Tang, C., Summers, M. F., and Mitsuya, H. (2002). Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors. J. Biol. Chem. 277, 5952-5961.
29. Goff, S. P. (2004). Retrovirus restriction factors. Mol. Cell 16, 849-859.
30. Hahn, B. H., Shaw, G. M., De Cock, K. M., and Sharp, P. M. (2000). AIDS as a zoonosis: scientific and public health implications. Science 287, 607-614.
31. Hartley, J. W., Rowe, W. P., and Huebner, R. J. (1970). Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures. J. Virol. 5, 221-225.
32. Hatziioannou, T., Cowan, S., Goff, S. P., Bieniasz, P. D., and Towers, G. J. (2003). Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J. 22, 385-394.
33. Hatziioannou, T., Perez-Caballero, D., Yang, A., Cowan, S., and Bieniasz, P. D. (2004). Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc. Natl. Acad. Sci. U.S.A. 101, 10774-10779.
34. Hilditch, L., Matadeen,R., Goldstone, D. C., Rosenthal, P. B., Taylor, I. A., and Stoye, J. P. (2011). Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1. Proc. Natl. Acad. Sci. U.S.A. 108, 5771-5776.
35. Himathongkham, S., and Luciw, P. A. (1996). Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 219, 485-488.
36. Hofmann, W., Schubert, D., Labonte, J., Munson, L., Gibson, S., Scammell, J., Ferrigno, P., and Sodroski, J. (1999). Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73, 10020-10028.
37. Ibe, S., Shigemi, U., Sawaki, K., Fujisaki, S., Hattori, J.,Yokomaku,Y.,Mamiya, N., Hamaguchi, M., and Kaneda, T. (2008). Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naive individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity. AIDS Res. Hum. Retroviruses 24, 1121-1125.
38. Ibe, S., Yokomaku, Y., Shiino, T., Tanaka, R., Hattori, J., Fujisaki, S., Iwatani, Y., Mamiya, N., Utsumi, M., Kato, S., Hamaguchi, M., and Sugiura, W. (2010). HIV-2 CRF01_AB: first circulating recombinant form of HIV-2. J. Acquir. Immune Defic. Syndr. 54, 241-247.
39. Javanbakht, H., An, P., Gold, B., Petersen, D. C., O'Huigin, C., Nelson, G. W., O'Brien, S. J., Kirk, G. D., Detels, R., Buchbinder, S., Donfield, S., Shulenin, S., Song, B., Perron, M. J., Stremlau, M., Sodroski, J., Dean, M., and Winkler, C. (2006). Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. Virology 354, 15-27.
40. Johnson, W. E., and Sawyer, S. L. (2009). Molecular evolution of the anti-retroviral TRIM5 gene. Immuno-genetics 61, 163-176.
41. Jung, Y. T., and Kozak, C. A. (2000). A single amino acid change in the murine leukemia virus capsid gene responsible for the Fv1(nr) phenotype. J. Virol. 74, 5385-5387.
42. Kaiser, S. M., Malik, H. S., and Emerman, M. (2007). Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein. Science 316, 1756-1758.
43. Kar, A. K., Diaz-Griffero, F., Li, Y., Li, X., and Sodroski, J. (2008). Biochemical and biophysical characterization of a chimeric TRIM21-TRIM5alpha protein. J. Virol. 82, 11669-11681.
44. Kawai, T., and Akira, S. (2011). Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins. EMBO Mol. Med. 3, 513-527.
45. Keckesova, Z., Ylinen, L. M., and Towers, G. J. (2004). The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retro-viral restriction factor activities. Proc. Natl. Acad. Sci. U.S.A. 101, 10780-10785.
46. Kim, J., Tipper, C., and Sodroski, J. (2011). Role of TRIM5alpha RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus. J. Virol. 85, 8116-8132.
47. Kirmaier, A., Wu, F., Newman, R. M., Hall, L. R., Morgan, J. S., O'Connor, S., Marx, P. A., Meythaler, M., Goldstein, S., Buckler-White, A., Kaur, A., Hirsch, V. M., and Johnson, W. E. (2010). TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol. 8, e1000462. doi:10.1371/journal.pbio.1000462
48. Kono, K., Song, H., Shingai, Y., Shioda, T., and Nakayama, E. E. (2008). Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection. Virology 373, 447-456.
49. Kono, K., Song, H.,Yokoyama, M., Sato, H., Shioda, T., and Nakayama, E. E. (2010). Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5alpha-mediated restriction. Retrovirology 7, 72.
50. Kootstra, N. A., Navis, M., Beugeling, C., Van Dort, K. A., and Schuitemaker, H. (2007). The presence of the Trim5alpha escape mutation H87Q in the capsid of late stage HIV-1 variants is preceded by a prolonged asymptomatic infection phase. AIDS 21, 2015-2023.
51. Kornbluth, R. S., Oh, P. S., Munis, J. R., Cleveland, P. H., and Richman, D. D. (1989). Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169, 1137-1151.
52. Kozak, C. A. (1985). Analysis of wild-derived mice for Fv-1 and Fv-2 murine leukemia virus restriction loci: a novel wild mouse Fv-1 allele responsible for lack of host range restriction. J. Virol. 55, 281-285.
53. Kozak, C. A., and Chakraborti, A. (1996). Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance. Virology 225, 300-305.
54. Kuang, Y. Q., Tang, X., Liu, F. L., Jiang, X. L., Zhang, Y. P., Gao, G., and Zheng, Y. T. (2009). Genotyping of TRIM5 locus in northern pig-tailed macaques (Macaca leonina), a primate species susceptible to human immunodeficiency virus type 1 infection. Retrovirology 6, 58.
55. Langelier, C. R., Sandrin, V., Eckert, D. M., Christensen, D. E., Chandrasekaran, V., Alam, S. L., Aiken, C., Olsen, J. C., Kar, A. K., Sodroski, J. G., and Sundquist, W. I. (2008). Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication. J. Virol. 82, 11682-11694.
56. Leligdowicz, A., Onyango, C., Yindom, L. M., Peng, Y., Cotten, M., Jaye, A., Mcmichael, A., Whittle, H., Dong, T., and Rowland-Jones, S. (2010). Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infection. Eur. J. Immunol. 40, 1963-1972.
57. Leslie, A. J., Pfafferott, K. J., Chetty, P., Draenert, R., Addo, M. M., Feeney, M., Tang, Y., Holmes, E. C., Allen, T., Prado, J. G., Altfeld, M., Brander, C., Dixon, C., Ramduth, D., Jeena, P., Thomas, S. A., St John, A., Roach, T. A., Kupfer, B., Luzzi, G., Edwards, A., Taylor, G., Lyall, H., Tudor-Williams, G., Novelli, V., Martinez-Picado, J., Kiepiela, P., Walker, B. D., and Goulder, P. J. (2004). HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10, 282-289.
58. Li, X., and Sodroski, J. (2008). The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association. J. Virol. 82, 11495-11502.
59. Lilly, F. (1967). Susceptibility to two strains of Friend leukemia virus in mice. Science 155, 461-462.
60. Lilly, F. (1970). Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice. J. Natl. Cancer Inst. 45, 163-169.
61. Lin, T. Y., and Emerman, M. (2008). Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1. Virology 379, 335-341.
62. Liu, F. L., Qiu, Y. Q., Li, H., Kuang, Y. Q., Tang, X., Cao, G., Tang, N. L., and Zheng, Y. T. (2011). An HIV-1 resistance polymorphism in TRIM5alpha gene among Chinese intravenous drug users. J. Acquir. Immune Defic. Syndr. 56, 306-311.
63. Locher, C. P., Blackbourn, D. J., Herndier, B. G., Reyes-Teran, G., Barnett, S. W., Murthy, K. K., and Levy, J. A. (1998). Transient virus infection and pathogenesis of a new HIV type 2 isolate, UC12, in baboons. AIDS Res. Hum. Retro-viruses 14, 79-82.
64. Locher, C. P., Witt, S. A., Herndier, B. G., Abbey, N. W., Tenner-Racz, K., Racz, P., Kiviat, N. B., Murthy, K. K., Brasky, K., Leland, M., and Levy, J. A. (2003). Increased virus replication and virulence after serial passage of human immunodeficiency virus type 2 in baboons. J. Virol. 77, 77-83.
65. Maegawa, H., Miyamoto, T., Sakuragi, J., Shioda, T., and Nakayama, E. E. (2010). Contribution of RING domain to retrovirus restriction by TRIM5alpha depends on combination of host and virus. Virology 399, 212-220.
66. McEwan, W. A., Schaller, T., Ylinen, L. M., Hosie, M. J., Towers, G. J., and Willett, B. J. (2009). Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat. J. Virol. 83, 8270-8275.
67. Miyamoto, T., Yokoyama, M., Kono, K., Shioda, T., Sato, H., and Nakayama, E. E. (2011). A single amino acid of human immunodeficiency virus type 2 capsid protein affects conformation of two external loops and viral sensitivity to TRIM5alpha. PLoS ONE 6, e22779. doi:10.1371/journal.pone.0022779
68. Mortuza, G. B., Dodding, M. P., Goldstone, D. C., Haire, L. F., Stoye, J. P., and Taylor, I. A. (2008). Structure of B-MLV capsid amino-terminal domain reveals key features of viral tropism, gag assembly and core formation. J. Mol. Biol. 376, 1493-1508.
69. Mortuza, G. B., Haire, L. F., Stevens, A., Smerdon, S. J., Stoye, J. P., and Taylor, I. A. (2004). High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431, 481-485.
70. Munk, C., Brandt, S. M., Lucero, G., and Landau, N. R. (2002). A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. U.S.A. 99, 13843-13848.
71. Nakajima, T., Nakayama,E. E., Kaur, G., Terunuma, H., Mimaya,J. I., Ohtani, H., Mehra, N., Shioda, T., and Kimura, A. (2009). Impact of novel TRIM5alpha variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection. AIDS 23, 2091-2100.
72. Nakayama, E. E., Carpentier, W., Costagliola, D., Shioda, T., Iwamoto, A., Debre, P., Yoshimura, K., Autran, B., Matsushita, S., and Theodorou, I. (2007). Wild type and H43Y variant of human TRIM5alpha show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro. Immunogenetics 59, 511-515.
73. Nakayama, E. E., Miyoshi, H., Nagai, Y., and Shioda, T. (2005). A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. J. Virol. 79, 8870-8877.
74. Nakayama, E. E., and Shioda, T. (2010). Anti-retroviral activity of TRIM5 alpha. Rev. Med. Virol. 20, 77-92.
75. Nakayama, E. E., and Shioda, T. (2012). TRIM5α and species tropism of HIV/SIV. Front. Microbiol. 3:13. doi:10.3389/fmicb.2012.00013
76. Newman, R. M., Hall, L., Connole, M., Chen, G. L., Sato, S., Yuste, E., Diehl,W.,Hunter, E.,Kaur,A., Miller, G. M., and Johnson, W. E. (2006). Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha. Proc. Natl. Acad. Sci. U.S.A. 103, 19134-19139.
77. Newman, R. M., Hall, L., Kirmaier, A., Pozzi, L. A., Pery, E., Farzan, M., O'Neil, S. P., and Johnson, W. (2008). Evolution of a TRIM5-CypA splice isoform in old world monkeys. PLoS Pathog. 4, e1000003. doi:10.1371/journal.ppat.1000003
78. Nisole, S., Lynch, C., Stoye, J. P., and Yap, M. W. (2004). A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc. Natl. Acad. Sci. U.S.A. 101, 13324-13328.
79. O'Brien, S. J., and Nelson, G. W. (2004). Human genes that limit AIDS. Nat. Genet. 36, 565-574.
80. Odaka, T., and Yamamoto, T. (1965). Inheritance of susceptibility to Friend mouse leukemia virus. 11. Spleen foci method applied to test the susceptibility of crossbred progeny between a sensitive and a resistant strain. Jpn. J. Exp. Med. 35, 311-314.
81. Ohkura, S., Goldstone, D. C., Yap, M. W., Holden-Dye, K., Taylor, I. A., and Stoye, J. P. (2011). Novel escape mutants suggest an extensive TRIM5alpha binding site spanning the entire outer surface of the murine leukemia virus capsid protein. PLoS Pathog. 7, e1002011. doi:10.1371/journal.ppat.1002011
82. Ohkura, S., Yap, M. W., Sheldon, T., and Stoye, J. P. (2006). All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. J. Virol. 80, 8554-8565.
83. Ohmine, S., Sakuma, R., Sakuma, T., Thatava, T., Takeuchi, H., and Ikeda, Y. (2011). The antiviral spectra of TRIM5alpha orthologues and human TRIM family proteins against lentiviral production. PLoS ONE 6, e16121. doi:10.1371/journal.pone.0016121
84. Onyango, C. O., Leligdowicz, A., Yokoyama, M., Sato, H., Song, H., Nakayama, E. E., Shioda, T., De Silva, T., Townend, J., Jaye, A., Whittle, H., Rowland-Jones, S., and Cotten, M. (2010). HIV-2 capsids distinguish high and low virus load patients in a West African community cohort. Vaccine 28S2, B60-B67.
85. Ovsyannikova, I. G., Dhiman, N., Haralambieva, I. H., Vierkant, R. A., O'Byrne, M. M., Jacobson, R. M., and Poland, G. A. (2010). Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum. Genet. 127, 207-221.
86. Pacheco, B., Finzi, A., Stremlau, M., and Sodroski, J. (2010). Adaptation of HIV-1 to cells expressing rhesus monkey TRIM5alpha. Virology 408, 204-212.
87. Perez-Caballero, D., Hatziioannou, T., Yang, A., Cowan, S., and Bieniasz, P. D. (2005). Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. J. Virol. 79, 8969-8978.
88. Perez-Caballero, D., Soll, S. J., and Bieniasz, P. D. (2008). Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteins. PLoS Pathog. 4, e1000181. doi:10.1371/journal.ppat.1000181
89. Perron, M. J., Stremlau, M., and Sodroski, J. (2006). Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha. J. Virol. 80, 5631-5636.
90. Perron, M. J., Stremlau, M., Song, B., Ulm, W., Mulligan, R. C., and Sodroski, J. (2004). TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. U.S.A. 101, 11827-11832.
91. Pertel, T., Hausmann, S., Morger, D., Zuger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D., Chatel, L., Bisiaux, A., Albert, M. L., Strambio-De-Castillia, C., Mothes, W., Pizzato, M., Grutter, M. G., and Luban, J. (2011). TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361-365.
92. Pincus, T., Hartley, J. W., and Rowe, W. P. (1975). A major genetic locus affecting resistance to infection with murine leukemia viruses. IV. Dose-response relationships in Fv-1-sensitive and resistant cell cultures. Virology 65, 333-342.
93. Pincus, T., Rowe, W. P., and Lilly, F. (1971). A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus. J. Exp. Med. 133, 1234-1241.
94. Poulsen, A. G., Kvinesdal, B., Aaby, P., Molbak, K., Frederiksen, K., Dias, F., and Lauritzen, E. (1989). Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet 1, 827-831.
95. Price, A. J., Marzetta, F., Lammers, M., Ylinen, L. M., Schaller, T., Wilson, S. J., Towers, G. J., and James, L. C. (2009). Active site remodeling switches HIV specificity of antiretro-viral TRIMCyp. Nat. Struct. Mol. Biol. 16, 1036-1042.
96. Price, H., Lacap, P., Tuff, J., Wachihi, C., Kimani, J., Ball, T. B., Luo, M., and Plummer, F. A. (2010). A TRIM5alpha exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort. AIDS 24, 1813-1821.
97. Pryciak,P.M.,andVarmus,H.E.(1992). Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro. J. Virol. 66, 5959-5966.
98. Reynolds, M. R., Sacha, J. B., Weiler, A. M., Borchardt, G. J., Glidden, C. E., Sheppard, N. C., Norante, F. A., Castrovinci, P. A., Harris, J. J., Robertson, H. T., Friedrich, T. C., Mcdermott, A. B., Wilson, N. A., Allison, D. B., Koff, W. C., Johnson, W. E., and Watkins, D. I. (2011). The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challenge. J. Virol. 85, 9637-9640.
99. Rowland-Jones, S. L., and Whittle, H. C. (2007). Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1? Nat. Immunol. 8, 329-331.
100. Saito, A., Kono, K., Nomaguchi, M., Yasutomi, Y., Adachi, A., Shioda, T., Akari, H., and Nakayama, E. E. (2012). Geographic, genetic and functional diversity of antiretroviral host factor TRIMCyp in cynomol-gus macaque (Macaca fascicularis). J. Gen. Virol. 93, 594-602.
101. Sakuma, R., Mael, A. A., and Ikeda, Y. (2007a). Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells. J. Virol. 81, 10201-10206.
102. Sakuma,R.,Noser,J.A.,Ohmine,S.,and Ikeda, Y. (2007b). Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins. Nat. Med. 13, 631-635.
103. Sakuma, R., Ohmine, S., and Ikeda, Y. (2010). Determinants for the rhesus monkey TRIM5alpha-mediated block of the late phase of HIV-1 replication. J. Biol. Chem. 285, 3784-3793.
104. Sakuma, R., Ohmine, S., Mael, A. A., Noser, J. A., and Ikeda, Y. (2008). Reply to: no effect of endogenous TRIM5alpha on HIV-1 production. Nat. Med. 14, 236-238.
105. Sawyer, S. L., Emerman, M., and Malik, H. S. (2007). Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog. 3, e197. doi:10.1371/journal.ppat.0030197
106. Sawyer, S. L., Wu, L. I., Akey, J. M., Emerman, M., and Malik, H. S. (2006). High-frequency persistence of an impaired allele of the retro-viral defense gene TRIM5alpha in humans. Curr. Biol. 16, 95-100.
107. Sawyer, S. L., Wu, L. I., Emerman, M., and Malik, H. S. (2005). Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. U.S.A. 102, 2832-2837.
108. Sayah, D. M., Sokolskaja, E., Berthoux, L., and Luban, J. (2004). Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430, 569-573.
109. Schaller, T., Hue, S., and Towers, G. J. (2007). An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins. J. Virol. 81, 11713-11721.
110. Sebastian, S., and Luban, J. (2005). TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2, 40.
111. Shi, M., Deng, W., Bi, E., Mao, K., Ji, Y., Lin, G., Wu, X., Tao, Z., Li, Z., Cai, X., Sun, S., Xiang, C., and Sun,B. (2008). TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9, 369-377.
112. Shibata, R., Sakai, H., Kawamura, M., Tokunaga, K., and Adachi, A. (1995). Early replication block of human immunodeficiency virus type 1 in monkey cells. J. Gen. Virol.76(Pt 11), 2723-2730.
113. Shioda, T., and Nakayama, E. E. (2006). Human genetic polymorphisms affecting HIV-1 diseases. Int. J. Hematol. 84, 12-17.
114. Song, B., Gold, B., O'Huigin, C., Javanbakht, H., Li, X., Stremlau, M., Winkler, C., Dean, M., and Sodroski, J. (2005a). The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. J. Virol. 79, 6111-6121.
115. Song, B., Javanbakht, H., Perron, M., Park, D. H., Stremlau, M., and Sodroski, J. (2005b). Retrovirus restriction by TRIM5alpha variants from old world and new world primates. J. Virol. 79, 3930-3937.
116. Song, H., Nakayama, E. E., Yokoyama, M., Sato, H., Levy, J. A., and Shioda, T. (2007). A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas. J. Virol. 81, 7280-7285.
117. Speelmon, E. C., Livingston-Rosanoff, D., Li, S. S., Vu, Q., Bui, J., Geraghty, D. E., Zhao, L. P., and Mcelrath, M. J. (2006). Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection. J. Virol. 80, 2463-2471.
118. Stevens, A., Bock, M., Ellis, S., Letissier, P., Bishop, K. N., Yap, M. W., Taylor, W., and Stoye, J. P. (2004). Retroviral capsid determinants of Fv1 NB and NR tropism. J. Virol. 78, 9592-9598.
119. Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., and Sodroski, J. (2004). The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853.
120. Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., and Sodroski, J. (2006). Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U.S.A. 103, 5514-5519.
121. Stremlau, M., Perron, M., Welikala, S., and Sodroski, J. (2005). Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J. Virol. 79, 3139-3145.
122. Tareen, S. U., and Emerman, M. (2011). Human Trim5alpha has additional activities that are uncoupled from retroviral capsid recognition. Virology 409, 113-120.
123. Tareen, S. U., Sawyer, S. L., Malik, H. S., and Emerman, M. (2009). An expanded clade of rodent Trim5 genes. Virology 385, 473-483.
124. Torimiro, J. N., Javanbakht, H., Diaz-Griffero, F., Kim, J., Carr, J. K., Carrington, M., Sawitzke, J., Burke,D. S., Wolfe, N. D.,Dean, M.,and Sodroski, J. (2009). A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies. Virology 391, 140-147.
125. Towers, G., Bock, M., Martin, S., Takeuchi, Y., Stoye, J. P., and Danos, O. (2000). A conserved mechanism of retrovirus restriction in mammals. Proc. Natl. Acad. Sci. U.S.A. 97, 12295-12299.
126. Towers, G., Collins, M., and Takeuchi, Y. (2002). Abrogation of Ref1 retro-virus restriction in human cells. J. Virol. 76, 2548-2550.
127. Uchil, P. D., Quinlan, B. D., Chan, W. T., Luna, J. M., and Mothes, W. (2008). TRIM E3 ligases interfere with early and late stages of the retro-viral life cycle. PLoS Pathog. 4, e16. doi:10.1371/journal.ppat.0040016
128. van Manen, D., Rits, M. A., Beugeling, C., Van Dort, K., Schuitemaker, H., and Kootstra, N. A. (2008). The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection. PLoS Pathog. 4, e18. doi:10.1371/journal.ppat.0040018
129. Virgen, C. A., Kratovac, Z., Bieniasz, P. D., and Hatziioannou, T. (2008). Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc. Natl. Acad. Sci. U.S.A. 105, 3563-3568.
130. Wilson, S. J., Webb, B. L., Maplanka, C., Newman, R. M., Verschoor, E. J., Heeney, J. L., and Towers, G. J. (2008a). Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities. J. Virol. 82, 7243-7247.
131. Wilson, S. J., Webb, B. L., Ylinen, L. M., Verschoor, E., Heeney, J. L., and Towers, G. J. (2008b). Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc. Natl. Acad. Sci. U.S.A. 105, 3557-3562.
132. Wu, X., Anderson, J. L., Campbell, E. M., Joseph, A. M., and Hope, T. J. (2006). Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc. Natl. Acad. Sci. U.S.A. 103, 7465-7470.
133. Xu, L., Yang, L., Moitra, P. K., Hashimoto, K., Rallabhandi, P., Kaul, S., Meroni, G., Jensen, J. P., Weissman, A. M., and D'Arpa, P. (2003). BTBD1 and BTBD2 colo-calize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta. Exp. Cell Res. 288, 84-93.
134. Yap, M. W., Nisole, S., Lynch, C., and Stoye, J. P. (2004). Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. U.S.A. 101, 10786-10791.
135. Yap, M. W., Nisole, S., and Stoye, J. P. (2005). A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Curr. Biol. 15, 73-78.
136. Yap,M. W., and Stoye, J. P. (2003). Intra-cellular localisation of Fv1. Virology 307, 76-89.
137. Yeh, W. W., Rao, S. S., Lim, S. Y., Zhang, J., Hraber, P. T., Brassard, L. M., Luedemann, C., Todd, J. P., Dodson, A., Shen, L., Buzby, A. P., Whitney, J. B., Korber, B. T., Nabel, G. J., Mascola, J. R., and Letvin, N. L. (2011). The TRIM5 gene modulates penile mucosal acquisition of simian immunodeficiency virus in rhesus monkeys. J. Virol. 85, 10389-10398.
138. Ylinen, L. M., Keckesova, Z., Wilson, S. J., Ranasinghe, S., and Towers, G. J. (2005). Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles. J. Virol. 79, 11580-11587.
139. Ylinen, L. M., Price, A. J., Rasaiyaah, J., Hue, S., Rose, N. J., Marzetta, F., James, L. C., and Towers, G. J. (2010). Conformational adaptation of Asian macaque TRIM-Cyp directs lineage specific antiviral activity. PLoS Pathog. 6, e1001062. doi:10.1371/journal.ppat.1001062
140. Zhang, F., Perez-Caballero, D., Hatziioannou, T., and Bieniasz, P. D. (2008). No effect of endogenous TRIM5alpha on HIV-1 production. Nat. Med. 14, 235-236; author reply 236-238.
141. Zhang, X., Kondo, M., Chen, J., Miyoshi, H., Suzuki, H., Ohashi, T., and Shida, H. (2010). Inhibitory effect of human TRIM5alpha on HIV-1 production. Microbes Infect. 12, 768-777.